Dr. med. Sebastian Zundler

Professur für Immunzellmigration TT (Else Kröner Clinician Scientist-Professur) Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology

E-type prostanoid receptor 4 drives resolution of intestinal inflammation by blocking epithelial necroptosis (2021) Patankar J, Muller TM, Kantham S, Acera MG, Mascia F, Scheibe K, Mahapatro M, et al. Journal article Targeting Immune Cell Trafficking – Insights From Research Models and Implications for Future IBD Therapy (2021) Wiendl M, Becker E, Müller T, Voskens C, Neurath M, Zundler S Journal article, Review article Dynamic imaging of iel-iec co-cultures allows for quantification of cd103-dependent t cell migration (2021) Enderle K, Dinkel M, Spath EM, Schmid B, Zundler S, Tripal P, Neurath M, et al. Journal article Circulating Adaptive Immune Cells Expressing the Gut Homing Marker α4β7 Integrin Are Decreased in COVID-19 (2021) Müller T, Becker E, Wiendl M, Schulze L, Voskens C, Kremer A, Neurath M, et al. Journal article Intestinal Mucosal Wound Healing and Barrier Integrity in IBD–Crosstalk and Trafficking of Cellular Players (2021) Sommer K, Wiendl M, Müller T, Heidbreder K, Voskens C, Neurath M, Zundler S Journal article, Review article The JAK1/3 Inhibitor to Tofacitinib Suppresses T Cell Homing and Activation in Chronic Intestinal Inflammation (2021) Gerlach K, Lechner K, Popp V, Offensperger L, Zundler S, Wiendl M, Becker E, et al. Journal article Severe Acute Respiratory Syndrome Coronavirus 2 Attachment Receptor Angiotensin-Converting Enzyme 2 Is Decreased in Crohn's Disease and Regulated By Microbial and Inflammatory Signaling (2021) Patankar JV, Lehmann M, Kühl AA, Atreya R, Becker C, Gonzalez-Acera M, Schmitt H, et al. Journal article Total Recall: Intestinal T-RM Cells in Health and Disease (2021) Paap EM, Müller T, Sommer K, Neurath M, Zundler S Journal article, Review article Shear Wave Dispersion Imaging for the Characterization of Focal Liver Lesions - A Pilot study (2021) Jesper D, Fiedler S, Klett D, Waldner M, Schellhaas B, Zundler S, Neurath M, Pfeifer L Journal article Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab (2021) Fischer S, Cohnen S, Klenske E, Schmitt H, Vitali F, Hirschmann S, Ramming A, et al. Journal article